Have you been diagnosed with multiple myeloma? Did you recently start, or are you preparing to start, maintenance therapy with an oral (pill form) anticancer medication? You may be able to participate in a research study to help learn more about how taking your cancer medication affects your symptoms and quality of life and how cancer care costs may affect your life. Compensation provided.
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell that plays an important role in the immune system. Over time, myeloma cells build up in the bone marrow, which can lead to pain, tumor growth, weak bones, difficulty fighting infections, and other health problems. Although there is no cure for the disease, medications and other therapies can help manage multiple myeloma and reduce symptoms.
The purpose of this study is to find out how medication adherence (taking medications as prescribed) affects pain and quality of life in people who have multiple myeloma and to better understand how cancer care costs affect the lives of people with multiple myeloma. Researchers hope their findings lead to better ways to help people with multiple myeloma manage their disease and symptoms in the future.
COULD THIS STUDY BE RIGHT FOR YOU?
- Diagnosed with multiple myeloma
- Started maintenance therapy with an oral (pill form) anticancer medication in the past 30 days or plan to start soon
WHAT PARTICIPANTS CAN EXPECT
This study involves three in-person visits that will last about 30-45 minutes each. All in-person visits will be scheduled to take place with your regular clinic appointments whenever possible. If you are unable to attend in-person visits, the study team may be able to provide other options to participate.
IRB:STUDY20040013 - Understanding Oral Anticancer Medication Adherence among Patients with Multiple Myeloma
MEET THE RESEARCHER
Sarah M. Belcher, PhD, RN, OCN, is an Assistant Professor in the department of Health & Community Systems in the School of Nursing at the University of Pittsburgh and is also a member of the UPMC Hillman Cancer Center. Dr. Belcher received her BSN at The Ohio State University and was an Oncology Nursing Intern at Duke University Medical Center. She later earned her PhD at the University of Pittsburgh School of Nursing and completed her postdoctoral training at Emory University Nell Hodgson Woodruff School of Nursing. Dr. Belcher’s research is focused on improving health outcomes among patients with cancer who are experiencing the cumulative effects of cancer and cancer treatment, particularly among socioeconomically disadvantaged and underserved populations.